Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02232958 · ClinicalTrials.gov registry record · NA
Effect of HBO on Functional Connectivity of Resting State Networks in Patients With Cerebral Small Vessel Disease
A NA study, sponsored by St. Luke's Hospital, Chesterfield, Missouri.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02232958 is a NA study that was terminated before completion, run by St. Luke's Hospital, Chesterfield, Missouri. The registered enrollment target is 20 participants.
The verdict
NCT02232958, a NA study, was terminated before completion, sponsored by St. Luke's Hospital, Chesterfield, Missouri.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to extend our previous work, in which we demonstrated an increase in the internal and cross network connectivity of resting state neural networks in patients with cerebral small vessel disease by treatment with hyperbaric oxygen, to at least 20 more individuals.
Interventions
- OTHER Hyperbaric Oxygen Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-09-16 |
| Est. Completion | 2017-10-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02232958
The ClinicalTrials.gov registry entry for NCT02232958 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Luke's Hospital, Chesterfield, Missouri, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hyperbaric Oxygen Treatment is the first listed.
NCT02232958 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02232958 about?
NCT02232958 is a clinical study titled "Effect of HBO on Functional Connectivity of Resting State Networks in Patients With Cerebral Small Vessel Disease". The purpose of this study is to extend our previous work, in which we demonstrated an increase in the internal and cross network connectivity of resting state neural networks in patients with cerebral small vessel disease by treatment with hyperbaric oxygen, to at least 20 more individuals.
What is the current status of trial NCT02232958?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2014-09-16. Estimated completion is 2017-10-04.
What interventions are being tested in trial NCT02232958?
The interventions under investigation include: Hyperbaric Oxygen Treatment (OTHER).
Who is sponsoring clinical trial NCT02232958?
This trial is sponsored by St. Luke's Hospital, Chesterfield, Missouri, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.